54 related articles for article (PubMed ID: 38737892)
1. Targeting Oncostatin M Receptor to Attenuate Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine.
Trinh J; Shin J; Rai V; Agrawal DK
Cardiol Cardiovasc Med; 2024; 8(3):206-214. PubMed ID: 38817407
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Targeting p27
Trinh J; Shin J; Rai V; Agrawal DK
Arch Intern Med Res; 2024; 7(2):73-79. PubMed ID: 38737892
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis.
Chen R; McVey DG; Shen D; Huang X; Ye S
J Am Heart Assoc; 2023 Oct; 12(20):e031121. PubMed ID: 37815057
[TBL] [Abstract][Full Text] [Related]
4. Oxidized Low-density Lipoproteins and Lipopolysaccharides Augment Carotid Artery Plaque Vulnerability in Hypercholesterolemic Microswine.
Nooti S; Rai V; Radwan MM; Thankam FG; Singh H; Chatzizisis YS; Agrawal DK
Cardiol Cardiovasc Med; 2023; 7(4):273-294. PubMed ID: 37577745
[TBL] [Abstract][Full Text] [Related]
5. Role of oncostatin-M in ECM remodeling and plaque vulnerability.
Patel P; Rai V; Agrawal DK
Mol Cell Biochem; 2023 Nov; 478(11):2451-2460. PubMed ID: 36856919
[TBL] [Abstract][Full Text] [Related]
6. New insights into fibrous cap thickness of vulnerable plaques assessed by optical coherence tomography.
Liu X; He W; Hong X; Li D; Chen Z; Wang Y; Chen Z; Luan Y; Zhang W
BMC Cardiovasc Disord; 2022 Nov; 22(1):484. PubMed ID: 36371146
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Crosstalk of Immune Response and Vascular Smooth Muscle Cells Phenotype Switch for Arteriovenous Fistula Maturation.
Rai V; Singh H; Agrawal DK
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233314
[TBL] [Abstract][Full Text] [Related]
8. LPS and oxLDL-induced S100A12 and RAGE expression in carotid arteries of atherosclerotic Yucatan microswine.
Singh H; Rai V; Agrawal DK
Mol Biol Rep; 2022 Sep; 49(9):8663-8672. PubMed ID: 35771356
[TBL] [Abstract][Full Text] [Related]
9. Complicated Carotid Artery Plaques and Risk of Recurrent Ischemic Stroke or TIA.
Kopczak A; Schindler A; Sepp D; Bayer-Karpinska A; Malik R; Koch ML; Zeller J; Strecker C; Janowitz D; Wollenweber FA; Hempel JM; Boeckh-Behrens T; Cyran CC; Helck A; Harloff A; Ziemann U; Poli S; Poppert H; Saam T; Dichgans M
J Am Coll Cardiol; 2022 Jun; 79(22):2189-2199. PubMed ID: 35523659
[TBL] [Abstract][Full Text] [Related]
10. Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis.
Poznyak AV; Sukhorukov VN; Zhuravlev A; Orekhov NA; Kalmykov V; Orekhov AN
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163076
[TBL] [Abstract][Full Text] [Related]
11. Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.
Kowara M; Cudnoch-Jedrzejewska A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919446
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cells in atherosclerosis: time for a re-assessment.
Grootaert MOJ; Bennett MR
Cardiovasc Res; 2021 Sep; 117(11):2326-2339. PubMed ID: 33576407
[TBL] [Abstract][Full Text] [Related]
13. The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer.
Ding L; Cao J; Lin W; Chen H; Xiong X; Ao H; Yu M; Lin J; Cui Q
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183020
[TBL] [Abstract][Full Text] [Related]
14. Understanding Vulnerable Plaques: Current Status and Future Directions.
Lee KY; Chang K
Korean Circ J; 2019 Dec; 49(12):1115-1122. PubMed ID: 31760703
[TBL] [Abstract][Full Text] [Related]
15. The Human-Specific and Smooth Muscle Cell-Enriched LncRNA SMILR Promotes Proliferation by Regulating Mitotic CENPF mRNA and Drives Cell-Cycle Progression Which Can Be Targeted to Limit Vascular Remodeling.
Mahmoud AD; Ballantyne MD; Miscianinov V; Pinel K; Hung J; Scanlon JP; Iyinikkel J; Kaczynski J; Tavares AS; Bradshaw AC; Mills NL; Newby DE; Caporali A; Gould GW; George SJ; Ulitsky I; Sluimer JC; Rodor J; Baker AH
Circ Res; 2019 Aug; 125(5):535-551. PubMed ID: 31339449
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
17. The role of smooth muscle cells in plaque stability: Therapeutic targeting potential.
Harman JL; Jørgensen HF
Br J Pharmacol; 2019 Oct; 176(19):3741-3753. PubMed ID: 31254285
[TBL] [Abstract][Full Text] [Related]
18. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
